TOP STORIES

• BUSINESS Aducanumab Gets “Negative Trend Vote” in Europe: Biogen/Eisai
  November 18, 2021

• REGULATORY 50 Billion Yen-Plus Peak Sales Projected for Pfizer’s Vynmac, Listing Set for Nov. 25
  November 17, 2021

• COMMENTARY MOF, MHLW Push Conflicting Narratives on Drug Cost Control; Macroeconomic Indexing Is a Major Focus Too
  November 16, 2021

• REGULATORY Japan to Use mRNA Jabs for Boosters, Pfizer Vaccine for Time Being: Panel
  November 16, 2021

• BUSINESS Ono to Pay 28 Billion Yen to Settle Opdivo Feud with Honjo
  November 15, 2021

• REGULATORY Govt to Provide Up to 2 Billion Yen per Oral COVID-19 Drug to Support Development
  November 15, 2021

• BUSINESS Aikomi, Sumitomo Dainippon Eye Therapeutic App Approval for BPSD by 2027
  November 12, 2021

• ORGANIZATION Ex-MHLW Bureau Chief Calls for 6% Adjustment Rate, Frowns on Macroeconomic Indexing; Study Group Launch Next Month
  November 11, 2021

• REGULATORY Japan Approves Pfizer COVID-19 Vaccine for Booster Use
  November 11, 2021

• REGULATORY Japan to Receive 1.6 Million Courses of MSD’s COVID-19 Drug
  November 11, 2021

• BUSINESS Pfizer’s COVID-19 Vaccine Filed for Children 5 to 11 in Japan
  November 10, 2021

• BUSINESS 6 Wholesalers Raided over Suspected Bid-Rigging in Kyushu
  November 10, 2021

• REGULATORY Japan Drug Spending Up 2.3% Annually Since 2000, Outstripping GDP Growth: MOF
  November 9, 2021

• REGULATORY MHLW Panel Tables Decision on Efient’s Preventive Use for ICD Recurrences; Lilly's Migraine Med, Jardiance's Heart Failure Indication OK'ed
  November 9, 2021

• REGULATORY Chuikyo Calls for Combining Multiple Steps to Curb Spend for Potential Super Big Sellers Like Aducanumab, No Objection to Listing
  November 8, 2021

• REGULATORY Japan Approves Ronapreve to Prevent Symptomatic COVID-19
  November 5, 2021

• BUSINESS New EA Pharma CEO Eager to Put Company Back on Growth Track by Boosting Its Sales Strength
  November 5, 2021

• REGULATORY Ronapreve Clears Key Panel for COVID-19 Prevention, SC Use
  November 5, 2021

• BUSINESS 7 Major Japan Drug Makers Net Two-Digit Growth in Combined H1 Sales on Flagship Brands, Upfront Income
  November 4, 2021

• BUSINESS Shionogi Wants to Pick Global Partner for Oral COVID-19 Drug by Year-End: President
  November 2, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 82
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• 90
• …
• Next ›
• 最終 »